Seeing Is Believing
Currently out of the existing stock ratings of Edward White, 306 are a BUY (97.76%), 6 are a HOLD (1.92%), 1 are a SELL (0.32%).
Analyst Edward White, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 26% that have a potential upside of 44.32% achieved within 108 days.
Edward White’s has documented 612 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IKT, Inhibikase Therapeutics at 16-Aug-2024.
Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for MRTX (MIRATI THER) at 11/15/2017. The price target of $17 was fulfilled within 1 day with a profit of $2.95 (21%) receiving and performance score of 209.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
13
$9.1 (233.33%)
29 days ago
0/1 (0%)
$11.13 (595.19%)
Buy
10
$6.1 (156.41%)
10
1 years 9 days ago
1/4 (25%)
$7.03 (236.70%)
28
Hold
7
$3.1 (79.49%)
7
1 years 8 months 23 days ago
2/4 (50%)
$2.8 (66.67%)
79
Buy
26
1 years 9 months 17 days ago
2/5 (40%)
$17.95 (222.98%)
182
Buy
28
2 years 9 months 21 days ago
1/3 (33.33%)
$18.49 (194.43%)
148
Which stock is Edward White is most bullish on?
Which stock is Edward White is most reserved on?
What Year was the first public recommendation made by Edward White?